We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

IMOJEV japanese encephalitis vaccine (live, attenuated) powder for injection vial plus diluent vial (162215)

ARTG ID 162215

ARTG Name

IMOJEV japanese encephalitis vaccine (live, attenuated) powder for injection vial plus diluent vial

Product name

IMOJEV japanese encephalitis vaccine (live, attenuated) powder for injection vial plus diluent vial

ARTG Date

23 August 2010

Registration Type

Medicine

Therapeutic good type

Medicine

Ingredients

Japanese encephalitis virus

Licence category

RE

Licence status

A

Summary

Product information

Consumer medicine information

Related information

IMOJEV japanese encephalitis vaccine (live, attenuated) powder for injection vial plus diluent vial, Biocelect Pty Ltd (On behalf of Substipharm), CON-1076

3 March 2023

Section 14 consent

Consent to import and supply while noncompliant with standards. The consent is effective from 3 March 2023 until 3 March 2024.
IMOJEV japanese encephalitis vaccine (live, attenuated) powder for injection vial plus diluent vial, Biocelect Pty Ltd (on behalf of Substipharm), CON-1210

14 February 2024

Section 14 consent

Consent to import and supply while noncompliant with standards. The consent is effective from 14 February 2024 until 30 June 2025.
IMOJEV japanese encephalitis vaccine (live, attenuated) powder for injection vial plus diluent vial, Sanofi-Aventis Australia Pty Ltd , CON-727

12 January 2021

Section 14 consent

Consent to Supply while noncompliant with standards. The consent is effective from 12 January 2021 until 22 May 2022.
IMOJEV japanese encephalitis vaccine (live, attenuated) powder for injection vial plus diluent vial, Sanofi-Aventis Australia Pty Ltd , CON-727

12 January 2021

Section 14 consent

Consent to Supply while noncompliant with standards. The consent is effective from 12 January 2021 until 22 May 2022.